Combination Product Overview: Fixed Dosage

10 June 2010 by CoreRx™ Pharmaceuticals

In today's competitive pharmaceutical environment, building and maintaining market share is paramount. With dwindling pipelines, limited resources and expiring patents, now, more that ever, combination products are being considered in drug development portfolios. However, regulatory hurdles, physician acceptance and market strategy are just a few considerations that one should address.

This free-to-download white paper from CoreRx® Pharmaceuticals covers specifics regarding fixed dosage combinations (FDCs), and will give your company a better understanding of the challenges ahead.